Loading clinical trials...
Loading clinical trials...
A Small-Sample-Size Clinical Study to Evaluate the Effectiveness and Safety of the Gastric Bypass Stent System in Treatment of Patients With Nonalcoholic Fatty Liver Disease.
Conditions
Interventions
Gastric Bypass Stent System in Treatment of Patients with Nonalcoholic Fatty Liver Disease
Locations
1
China
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
Start Date
December 15, 2022
Primary Completion Date
December 30, 2025
Completion Date
June 30, 2026
Last Updated
June 26, 2024
NCT07237750
NCT06564584
NCT00983463
NCT02581085
NCT05583344
NCT05877547
Lead Sponsor
Hangzhou Tangji Medical Technology Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions